Replies to post #38439 on Pluristem Therapeutics Inc (PSTI)

[xov]

zzaatt,

I completely agree. Longs should be in for the long term, while recognizing that news could come at any moment. I, for one, am willing to risk bad news for the possibility of good news sending the stock skyward.

A minor point of clarification: today’s news was for an Expanded Access Program, not compassionate use (which was already in effect). As I understand it, compassionate use is only for patients who have not responded to any approved treatment and are facing imminent death. The EAP, on the other hand, allows any patient access to the treatment, if they don’t qualify for the Phase II study. This should be a much larger eligible population (though apparently only 100 will be treated).